Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Thrombocythemia with distal limb defects is a rare, genetic syndrome with limb reduction defects characterized by thrombocytosis, unilateral transverse limb defects (ranging from absence of phalanges to absence of hand or forearm) and splenomegaly.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hereditary thrombocytosis with transverse limb defect.
3 publications have been identified in PubMed for hereditary thrombocytosis with transverse limb defect. Research spans Other (33%), Case Report / Case Series (33%), and Clinical Trial Publication (33%).
Unknown (2026). [PMID: 41501744](https://pubmed.ncbi.nlm.nih.gov/41501744/). *BMC Proc*. [Other]
Khan S (2025). [PMID: 41042754](https://pubmed.ncbi.nlm.nih.gov/41042754/). *PloS one*. [Clinical Trial Publication]
Zabeida A (2025). [PMID: 40778015](https://pubmed.ncbi.nlm.nih.gov/40778015/). *Research and practice in thrombosis and haemostasis*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center